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The effect of infusion ofhyperoncotic (25 g% salt-poor bovine plasma albumin) (0.06 g% of
body weight) has been studied using clearance and micropuncture techniques in animals with
two forms of immunologically induced experimental glomerulonephritis and in age-matched
control rats.
In control rats the significant natriuresis and diuresis after hyperoncotic albumin were
associated with decreased fractional and absolute proximal reabsorption, decreased calculated
efferent oncotic pressure, and a transitory rise in efferent arteriolar hydrostatic pressure.
These findings, however, do not necessarily indicate a predominant role for peritubular
"physical factors" in the control ofproximal reabsorption.
In glomerulonephritic rats a smaller diuresis and an insignificant natriuresis were found
after hyperoncotic albumin, especially in anti-GBM nephritis, when no change in SNGFR or
proximal absolute reabsorption occurred. In AICN there was a rise in SNGFR and a fall in
absolute reabsorptive rate, especially in those nephrons with high filtration rates. There was no
evidence that any alteration in efferent arteriolar hydrostatic pressure or calculated efferent
oncotic pressure had occurred.
Clinicians have long been familiar with the ability of hyperoncotic salt-poor
albumin infusion to result in a significant, though transient, natriuresis and diuresis
in patients with hypoproteinemia and edema (1-3). An initial rise in the plasma
albumin concentration has been found to accompany this diuresis, the largest in-
creases in albumin concentration being seen in those patients having the largest
diuresis (2). At first sight such an observation might seem to be at variance with cur-
rent concepts regarding the role of "physical factors" (oncotic and hydrostatic
pressure) in determining the rate of tubular reabsorption (4, 5). Thus, a rise in
peritubular oncotic pressure might be expected to be associated with an increase in
proximal tubular reabsorption and an antidiuretic effect.
Therefore, we have studied the acute effects ofinfusion of salt-poor hyperoncotic
albumin in rats with two forms of immunologically induced experimental
glomerulonephritis and in control animals, using clearance and micropuncture tech-
niques. The largest diuretic and natriuretic effect was found in the control rats,
where it was associated with a fall in both fractional and absolute proximal tubular
reabsorption, a fall in calculated efferent oncotic pressure, and a small rise in
efferent arteriolar hydrostatic pressure. No such changes were found in efferent ar-
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teriolar oncotic or hydrostatic pressure in either form of glomerulonephritis, al-
though a significant diuretic response was seen in both disease states, and in AICN a
significant fall in proximal absolute reabsorptive rate was also found. Hence, there
was no evidence that peritubular "physical factors" were important in the response
to hyperoncotic albumin infusion in glomerulonephritis.
METHODS
Autologous immune complex or Heymann's nephritis (AICN) (6-8) was induced
in 10 male Wistar rats by repeated injections of partially purified rat renal tubular
antigen emulsified in complete Freund's adjuvant (9). Antiglomerular basement
membrane (GBM) antibody induced glomerulonephritis was produced in five male
Wistar rats by intravenous injection of 200-275 jig of rabbit antirat GBM antibody
(9). The AICN rats were studied between 5 and 20 months after the first injection of
antigen, whereas the anti-GBM group was studied 10-38 days after injection of the
heterologous anti-GBM antibody. Eight large male Wistar rats, age matched with
the AICN animals, and three smaller animals of similar age to the anti-GBM group
were used as controls.
Clearance and micropuncture studies were carried out for approximately 2Y2 hr
before, during, and 112 hr after infusion of hyperoncotic (25 g%) salt-poor bovine
plasma albumin (0.06 g% of body wt) (Armour Pharmaceutical Co., Chicago, Ill.
60690).
All animals were deprived of food but not of water overnight before study and
were anesthetized by intraperitoneal injection of sodium pentobarbital, 60 mg/k
body wt. They were prepared for micropuncture as previously described (10),
isotonic saline 0.5% of body wt being given during surgery to replace fluid losses.
Both ureters were cannulated with PE 10 polyethylene tubing. Blood pressure was
recorded from the carotid artery using a Statham P 23 Db transducer (Statham
Instruments, Inc., Oxnard, California) and a Beckman Dynograph Recorder
(Beckman Instrument, Inc., Fulton, California).
Intravenous infusion was commenced using modified Ringer's solution (NaCl 0.8
g/100 ml; KCL 0.042/100 ml; CaCl2 0.025 g/100 ml; NaHCO3 0.02 g/100 ml),
given intravenously at the rate of 0.4 ml/100 g body wt/hr, together with d-aldos-
terone (Ciba Pharmaceutical Co., Summit, N.J.), vasopressin (Parke, Davis and
Co., Detroit, Michigan), H3 methoxy inulin (International Chemical and Nuclear
Corp., Burbank, California), and in some instances C14 p-aminohippurate (PAH)
(New England Nuclear Corp., Boston, Mass.). In those rats in which intrarenal
pressure measurements were made, a priming dose of 3 jig of d-aldosterone, 60 jc
H3-inulin, and 2 jic PAH was followed by infusion of d-aldosterone, 2.4,ug/hr,
vasopressin 0.03,jg/hr, C14 PAH 5-7,ic/hr, and H3-inulin at the rate of 20 jic 100
body wt-' hr-'. When proximal tubular fluid (F/P) inulin levels were to be
measured, the latter was usually increased to 40-80 jic H3-inulin body wt-' hr-'.
Three consecutive timed urine collections, each lasting approximately 45-60 min,
were made from both kidneys. The intravenous infusion was then changed to one
containing 25 g% salt-poor bovine plasma albumin (sodium concentration 120.4 +
11.9 SD mM/liter) but otherwise identical to the previous infusion in terms of cal-
cium, bicarbonate, d-aldosterone, vasopressin, H3-inulin, and C14 PAH content.
This solution was infused at the rate of 0.4 ml 100 g body wt-' hr-' until a total of
0.06 g% of body wt of albumin had been given, generally over 30-40 min. A fourth
urine collection was obtained during this period. The original infusate was then
recommenced, and two 45-60-min collections made. There were thus a total of six
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consecutive timed urine collections, three before, one during, and two following hy-
peroncotic albumin. Blood (less than 30 Al) was obtained from the carotid artery
and left renal vein at approximately 45-min intervals for measurement of
hematocrit, protein, H3-inulin, and C14 PAH levels. Clearances were determined as
previously described (11). Glomerular filtration rate (GFR) was calculated sep-
arately for the left and right kidneys, renal plasma flow (RPF) for the left kidney
only.
In those rats not given C14 PAH, the left RPF was calculated as follows: RPF =
[V(U - R)]/(A - R), where V = urine flow rate and U, A, and R = inulin concen-
tration in urine, arterial plasma, and renal venous plasma, respectively. In those rats
given C14 PAH, RPF was calculated as follows: (C PAH)/(E PAH), where C =
clearance and E = extraction.
Two groups of micropuncture experiments were carried out. In the first series
(five AICN, five anti-GBM, and six control animals), the kidney was bathed with
mineral oil heated to 36 ± 10 C. The last loop ofa proximal tubule visible on the sur-
face of the kidney was identified by following the passage oflissamine green-colored
saline injected through a sharpened siliconized pipette, external tip diameter 4-6 ,um,
inserted into a superficial proximal convolution. The last convolution was then punc-
tured using a sharpened siliconized pipette, external diameter 11-12 ,um, and a
mineral oil block 4-5 tubular diameters in length was injected. Tubular fluid was
then collected, controlled suction being used to keep the oil block in place and the
tubular diameter constant if at all possible. The sample was pulled into the straight
part of the collection pipette using toluene, the length and diameter measured using
a micrometer and the volume calculated. The whole sample was then discharged
into counting fluid (PCS, Amersham/Searle, Arlington Heights, Ill.) and counted
using a Packard Tricarb liquid scintillation counter.
The following calculations were made:
SNGFR = F/P inulin x tubular flow rate in nanoliters/minute,
% reabsorption to the late convolution = I1 - [1/(F/P inulin)]} x 100,
absolute reabsorption = fractional reabsorption x SNGFR in nanoliters/minute.
In the second group (five AICN, five control rats), the kidney was bathed with
isotonic saline 36 i 1'C in order to allow the use of an electronic servo-nulling
device for measurement of hydrostatic pressure as previously described (12).
Sharpened siliconized glass pipettes, external tip diameter 3-5 ,um, filled with 2 M
NaCl, were used to measure hydrostatic pressure in proximal tubules during free-
flow, in the large efferent arteriolar "stars," in intermediate vessels, which arelarge-
diameter straight vessels and which often arise from stars, and in the larger
peritubular capillaries.
Serial plasma protein concentrations were measured before, during, and at the
end of each experiment by an adaptation of the Lowry technique (13) using a rat
serum protein standard. These values were used to calculate oncotic pressure by the
Landis and Pappenheimer equation (14):
ira = 2.1 Pa + 0.16 Pa2 + 0.009 Pa3.
This equation holds for rat protein concentrations estimated in this laboratory and
has been validated by measuring directly the serum oncotic pressure (G. Navar,
University of Mississippi Medical Center, Jackson, Mississippi, and W. Arends-
horst, University ofNorth Carolina, Chapel Hill).
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Efferent arteriolar protein concentration was calculated using the whole kidney
filtration fraction (FF):
efferent arteriolar protein concentration = afferent arteriolar protein
concentration/(l - whole kidney FF).
Blood was taken terminally for blood urea nitrogen determination (BUN),
measured on a Technicon autoanalyzer (Technicon Corp., Ardsley, New York) by a
modification of the carbamidodiacetyl fraction as applied to the determination of
urea nitrogen and cholesterol. Urine plasma electrolytes were measured using an IL
direct-reading flame photometer (Instrumentation Laboratories, Inc., Watertown,
Mass.). Fractional electrolyte excretion was calculated without use of the Donnan
factor. Determination of 24-hr urine protein concentration measured immediately
before study was made using either the Biuret technique or salicylsulphonic acid.
Results have been analyzed on a per rat basis using the paired Student's t test and
by analysis ofvariance.
Blood Volume Measurement
After the last clearance period was completed, the blood volume of the rat was
measured in seven AICN animals, four anti-GBM animals, and six control rats
using sodium chromate Cr 51-labeled red blood cells (Rachromate 51, Abbott Ra-
diopharmaceutical, N. Chicago, Ill. 60064). Blood was obtained from a male Wistar
rat, anticoagulated with A-C-D solution (Abbott Radiopharmaceutical), and in-
cubated with chromium 51 at room temperature for 30 min. The red cells were then
washed twice and resuspended at a hematocrit of 50% in isotonic saline. An ac-
curately measured volume of this solution was then injected intravenously, and a
blood sample was obtained after a further 30 min. The sample was counted in a
gamma counter, and the blood volume was calculated knowing the relative specific
activities ofthe samples and the hematocrit.
IMMUNOPATHOLOGIC STUDIES
At the end of each experiment, both kidneys from each animal were weighed and
bisected along the anterior-posterior axis. The halves were either fixed in Bouin's so-
lution for histological study or snap frozen (in liquid nitrogen or dry ice-alcohol
bath) for immunofluorescence studies as previously described (9). The immu-
nofluorescence studies utilized fluorescein isothiocyanate-conjugated antiserum
specific for rat IgG and C3 also as previously described (9). The histologic sections
were examined and graded for the following categories: glomerular hypercellularity,
necrosis, sclerosis, crescent formation; GBM thickening; overall architectural
derangement; interstitial infiltration; tubular atrophy, luminal cells, casts; and
thickening oftubular basement membrane.
RESULTS
Structural and functional changes in the kidneys of the animals with glomerulo-
nephritis were similar to those previously described by us in a similar group of ani-
mals (9). Histologically, AICN was typified by uniform thickening oftheglomerular
basement membrane (GBM), minimal glomerular hypercellularity, and granular
deposits of IgG and C3 diffusely along the GBM (Fig. 1). Anti-GBM nephritic
kidneys showed increased glomerular cellularity, polymorphonuclear leucocyte
infiltration, and crescent formation together with linear deposits of IgG and C3
along the GBM (Fig. 1). Although there was some individual variation among
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FIG. 1. (A) Uniform thickening of the GBM in the absence of proliferative changes typified the
membranous glomerulonephritis that characterized the glomerular lesions of the AICN rats. (B) Pro-
liferation of endothelial and epithelial cells characterized the proliferative glomerulonephritis induced in
the anti-GBM rats. An area ofproliferation ofthe epithelial cells of Bowman's capsule, so-called crescent
formation, is indicated by the arrows. (C) Innumerable fine granular deposits of rat immunoglobin (ac-
companied by complement C3) were observed uniformly along the GBM of the AICN rats. (D) Linear
accumulations of rat immunoglobulin (accompanied by complement C3 and rabbit immunoglobulin)
were observed outlining the GBM several days after the anti-GBM rats received rabbit anti-rat GBM an-
tibodies.
Figure IA, I B periodic acid-Schiff (PAS) stain, original magnification x 320. Figure IC, 1 D direct im-
munofluorescence using fluorescein isothiocyanate-conjugated rabbit anti-rat IgG antisera, original
magnification x250.
glomeruli, the severity ofglomerular damage was uniform throughout the cortex of
each individual kidney in both ofthese disease states.
The glomerular lesions in both forms ofglomerulonephritis were accompanied by
variable changes in the renal tubules and interstitium leading to different degrees of
derangement of renal architecture. The overall severity of the renal lesion corre-
sponded to the degree ofglomerular involvement and was much slower in developing
in the chronic membranous glomerulonephritis of the AICN rats than in the acute
proliferative, often crescent-forming, glomerular lesions induced by anti-GBM anti-
bodies (9).
Table 1 compares the 24-hr urinary protein excretion rate, initial plasma protein
concentration, hematocrit, cholesterol, and BUN in 10 AICN animals, five rats
with anti-GBM nephritis, and a total of 11 age-matched controls. The latter have
been divided into two groups, comparable in age and weight to the AICN and anti-
GBM nephritic animals. All the glomerulonephritic rats had very significant pro-
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TABLE 1
Proteinuria, Initial Plasma Protein Concentration and Hematocrit, and Terminal Cholesterol and
BUN Concentrations in Control and Glomerulonephritic Rats (Mean ± SD)
AICN Anti-GBM
AICN controls Anti-GBM controls
n= 10 p n=8 n=S p n=3
Body weight (g) 665 NS 658 275 NS 292
±53 ±91 ±50 ±48
Proteinuria (mg/24 hr) 440 <0.001 15.6 354 <0.001 18.0
±211 ±18 ±141 ±4
Plasma protein (go) 5.2 NS 5.6 4.7 NS 5.0
±0.4 ±0.4 ±0.9 ±0.7
Hematocrit (%) 44.5 NS 46.8 42.9 NS 51.0
±4.3 ±2.5 ±6.8 ±4.3
Cholesterol (mg%) 194 <0.005 72.4 194 NS 82.3
±78 ±12.9 ±92 ±15
BUN (mgo) 30.6 NS 26.7 44.8 NS 36.7
±8.9 ±9.7 ±17.8 ±9.0
teinuria, but neither group was significantly hypoproteinemic. None was edematous.
All had hypercholesterolemia. The mean BUN concentration was not significantly
elevated in either group.
ClearanceStudies
Clearance data are given for the left (L) kidney only, there being no statistical
difference between the right (R) and (L) GFR.
Figure 2 shows the mean values + SD for urine flow rate, sodium excretion, GFR,
RPF, and FF during the three periods prior to albumin, during albumin infusion,
and for the two periods immediately thereafter.
The mean values for urine flow rate, U/P inulin concentration, GFR, RPF,
filtration fraction, and electrolyte excretion for the control and glomerulonephritic
rats before albumin administration (Tables 2 and 3) are similar to those previously
reported by us in a similar group of animals (9), with a significant fall in GFR and
FF in both AICN and anti-GBM animals and a significant rise in RPF in the more
acute anti-GBM nephritis.
All animals then received 0.06 g% body wt of albumin iv as a 25 g% solution
during the fourth clearance period. Mean hematocrit fell 1 1.3% in large control rats,
6% in small control animals, 8.5% in AICN, and 7% in anti-GBM nephritis. Plasma
protein concentration increased significantly in all groups during albumin infusion
(Period 3 vs Period 4). However, the mean plasma protein concentration in the three
periods before albumin infusion did not differ from that in the three periods during
and after albumin infusion in any of thegroups (Fig. 3). A significant fall occurred in
plasma protein concentration in the large control rats and in animals with AICN
during the initial pre-albumin-clearance periods. A corresponding significant fall in
hematocrit was not observed.
In all control rats a significant increase in urine flow rate (average 185%) and in
absolute and fractional electrolyte excretion occurred, the maximum effect being
seen 45-90 min after starting the albumin infusion (Fig. 2). A similar, very
significant rise in urine flow rate (average 129%) and a significant, although less
marked, natriuretic response was found in rats with AICN. The smallest diuretic
and natriuretic effects were seen in animals with anti-GBM nephritis, urine flow rate
increasing on average by 103%.
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FIG. 2. Results before, during, and after infusion ofbovine serum albumin.
There was no significant change in mean GFR after albumin in either the larger,
older (AICN) or the smaller, younger (anti-GBM) control rats. Renal plasma flow
increased in both, but this reached statistical significance only in the larger rats.
Hence, whole kidney filtration fraction fell significantly only in this group ofcontrol
rats. In AICN both GFR and RPF increased significantly after albumin, FF
remaining unchanged. No significant change in GFR, RPF, or FF was seen in anti-
GBM nephritis.
The extraction of PAH was measured in five out of 11 control rats and fell
significantly after albumin from 0.87 + 0.01 SD to 0.60 i 0.10 SD (p < 0.001). A
fall was also seen in rats with both AICN and anti-GBM nephritis (0.67 ± 0.12 SD
to 0.56 i 0.06 SDn = 4,p < 0.025).ALLISON ET AL.
TABLE 2
Clearance Data (Left Kidney) in Control and Glomerulonephritic Rats Before (B), and During and
After (A) Hyperoncotic Salt-poor Albumin (Mean ± SD)
Urine
flow rate GFR RPF
(;Il min1l g (ml minl g (ml min1l g Filtration
kidney wt-1) U/P inulin kidney wt-1) kidney wt-1) fraction
B A B A B A B A B A
AICN 2.3 5.2a 223 ll6a 0.41 0.50a 3.89 4.84b 0.12 0.11
(n = 10) ±1.1 ±2.2 ±128 ±47 ±0.1 ±0.1 ±1.3 ±1.4 ±0.04 ±0.03
AICN 1.6 5.5b 626 254d 1.04 1.20 3.94 8.34c 0.28 0.16d
controls ±0.5 ±2.9 ±73 ±110 ±0.2 ±0.5 ±1.2 ±4.4 ±0.04 ±0.03
(n = 8)
Anti-GBM 1.7 3.5c 220 134 0.42 0.46 4.54 5.77 0.13 0.11
(n = 5) ±0.4 ±1.4 ±138 ±94 ±0.3 ±0.3 ±0.7 ±2.4 ±0.07 ±0.09
Anti-GBM 2.6 5.9c 387 171C 1.00 1.06 2.94 3.75 0.34 0.31
controls ±0.5 ±1.3 ±90 ±96 ±0.1 ±0.1 ±0.2 ±1.6 ±0.07 ±0.09
(n = 3)
ap <0.01, statistically significant result.
bp <0.005.
Cp <0.05.
dp <0.001.
Systemic blood pressure increased after albumin in all animals studied (Table 4),
but thisdid not reach statistical significance in the anti-GBM group.
Terminal blood volume, expressed as a function ofbody weight, was significantly
higher in rats with anti-GBM nephritis (Table 5), i.e., in those animals showing the
smallestdiuretic response to hyperoncotic albumin.
MicropunctureStudies
As previously reported by us (9), marked functional heterogeneity ofSNGFR and
proximal tubular hydrostatic pressure was present in the diseased kidneys. Mean
SNGFR, late proximal fractional reabsorption, and absolute reabsorption were
TABLE 3
Electrolyte Excretion (Left Kidney) in Control and Glomerulonephritic Rats Before (B), and During
and After (A) Hyperoncotic Salt-poor Albumin (Mean ± SD)
Sodium Potassium
excretion excretion Filtered load Filtered load
(,uequiv min1 g (Muequiv minr1 g sodium potassium
kidney wt-1) kidney wt-1) excreted (%) excreted (%)
B A B A B A B A
AICN 0.09 0.58a 0.34 0.66a 0.11 0.81a 17.0 24.8
±0.05 ±0.41 ±0.18 ±0.31 ±0.06 ±0.63 ±11.5 ±12.6
Control 0.07 1.22a 0.37 0.65a 0.05 0.96b 5.7 11.5b
±0.03 ±0.69 ±0.16 ±0.19 ±0.02 ±1.02 ±1.4 ±5.2
Anti-GBM 0.07 0.32 0.32 0.66 0.15 0.50b 27.3 28.6
±0.04 ±0.26 ±0.07 ±0.37 ±0.06 ±0.19 ±21.9 ±15.4
Control 0.12 1.26 0.41 0.58 0.09 0.88c 7.2 9.5
±0.08 ±0.84 ±0.12 ±0.10 ±0.05 ±0.43 ±1.8 ±1.3
ap < 0.005.
bp < 0.02.
cp < 0.05.
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FIG. 3. Systemic plasma protein concentration immediately after anesthesia (before surgery), during
the control periods, and during and after albumin infusion. Values are means i SE.
TABLE 4
Hydrostatic Pressure in Carotid Artery Before (B), and During and After (A) Hyperoncotic Albumin
in Control, AICN, and Anti-GBM Rats (Mean ± SD)
B (mm Hg) p A (mm Hg)
AICN 118.2 ± 12.0 <0.005 127.7 ± 11.3
AICN controls 105.8 ± 9.0 <0.01 115.0 ± 7.2
Anti-GBM 117.3 ± 17.0 NS 126.0 ± 7.3
Anti-GBM controls 110.6 ± 12.0 <0.025 123.4 ± 6.7
TABLE 5
Terminal Blood Volume in Seven AICN Rats, Six AICN Control Rats, and Four Animals with
Anti-GBM Nephritis (Mean ± SD)
(ml/100 g body wt)
AICN 4.24 ± 0.27
p NS
AICN controls 3.93 ± 0.48
p <0.01
Anti-GBM 5.27 ± 0.72
TABLE 6
Single Nephron Filtration Rate (SNGFR) and Late Proximal F/P Inulin Ratio (Mean ± SD) Before
(B), and During and After (A) Hyperoncotic Albumin in Six Rats with AICN, Three Age-matched
Controls, Five Anti-GBM Nephrotic Animals, and Three Age-matched Control Rats
SNGFR (nl/min) F/P inulin
B p A B p A
AICN 47.8 <0.025 58.2 2.04 <0.05 1.48
±18.5 +17.1 ±0.4 ±0.2
AICN controls 41.7 NS 45.4 2.71 1.78
+7.2 ±11.3 ±0.8 ±0.3
Anti-GBM 17.7 NS 22.9 1.81 <0.025 1.60
±8.6 ±8.1 ±0.2 ±0.1
Anti-GBM controls 31.2 NS 32.2 2.32 1.73
±8.7 ±9.3 ±0.6 ±0.5ALLISON ET AL.
TABLE 7
Absolute Reabsorption to Late Proximal Convolution and Calculated Efferent Oncotic Pressure in
Five AICN Rats, Six Control Rats, and Five Anti-GBM Animals, and Efferent Arteriolar and
Proximal Tubular Hydrostatic Pressure in Another Five AICN Rats and Five Control Rats
Before (B), and During and After (A) Hyperoncotic Albumin Infusion
Absolute
reabsorption Efferent oncotic Efferent arteriole Proximal tubular
(nl/min) pressure (mm Hg) pressure (mm Hg) pressure (mm Hg)
B A B A B A B A
AICN 24.4 16.8a 19.1 19.5 11.0 11.1 13.2 13.8
±8.2 ±8.8 ±1.8 ±1.5 ±1.8 ±1.3 ±4.2 ±5.3
AICN 25.0 18.4 26.5 20.5 13.0 13.5 11.9 12.1
controls ±7.3 ±6.3 ±2.2 ±3.1 ±1.0 ±1.7 ±1.1 ±1.5
Anti-GBM 8.2 9.0 14.9 15.6 - - - -
±4.2 ±3.8 ±4.2 ±5.1
Anti-GBM 17.2 11.6 30.1 30.0 - - - -
controls ±3.0 ±2.8 ±8.4 ±8.5
ap < 0.005.
significantly lower in the anti-GBM group than in the control animals (Tables 6 and
7). In animals with AICN, mean fractional but not absolute reabsorption was
significantly reduced, mean SNGFR increasing slightly. Efferent arteriolar oncotic
pressure, calculated using the whole kidney filtration fraction, was significantly
reduced below levels found in control rats in animals with both forms ofglomerulo-
nephritis.
The changes that occurred in these measurements during and after hyperoncotic
albumin infusion are shown in Fig. 4; mean values found are given in Tables 6 and 7.
Mean SNGFR increased in each group (large controls, 9%; small controls, 3%;
AICN, 22%; anti-GBM, 29%). These figures should be compared with the increases
found in whole kidney filtration rate (large controls, 15%; small controls, 6%;
AICN, 22%; anti-GBM, 9.5%). Proximal fractional reabsorption fell in all animals.
Absolute reabsorption also fell in control and AICN rats but not in the anti-GBM
group. In the large control rats, the fall in absolute reabsorption rate was associated
with a fall in calculated efferent oncotic pressure and a small rise in measured
efferent arteriolar hydrostatic pressure that reached statistical significance during
the fifth urine collection period (13.0 mm Hg ± 1.0 SD to 14.8 mm Hg 1 1.2 SD,
p <0.01).
Despite the marked heterogeneity in SNGFR in the glomerulonephritic kidneys,
absolute reabsorption to the late proximal convolution varied in direct proportion to
the individual single nephron filtration rate both before and after hyperoncotic
albumin (Fig. 5). In the AICN group, a significant change occurred in the shape of
this relationship after albumin, the largest fall in proximal absolute reabsorption
being seen in those nephrons with the highest rates ofglomerular filtration.
DISCUSSION
In our study, infusion of hyperoncotic salt-poor bovine albumin into normal hy-
dropenic Wistar rats given ADH and aldosterone resulted in expansion of plasma
volume and a significant natriuresis and diuresis and was associated with a
significant fall in proximal fractional reabsorption.
A review of the extensive literature concerning the effect ofhyperoncotic albumin
infusion in normal human subjects and in the experimental animal quickly reveals
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FIG. 4. Results before, during, and after infusion ofbovine serum albumin.
the results to be extremely variable and apparently influenced by such diverse fac-
tors as the pre-existing state of hydration, the duration and quantity of albumin
infused, the ionized serum calcium level, and the time of day (15-18). Thus, 24 yr
ago Welt and Orloffobserved that infusion of25 g% salt-poor hyperoncotic albumin
to themselves while undergoing a water diuresis had no effect on urinary sodium or
chloride excretion, unless given at night when an increase was found. Similarly,
clearance studies in theintact or isolated saline loaded dog kidney revealed enhanced
sodium reabsorption after albumin (19, 20). Levy and Levinsky (21) found a rise in
proximal fractional reabsorption in the dog during.infusion of 30% bovine albumin
or dextran, which coincided with a significant increase in systemic plasma protein
concentration.
In contrast, more recent micropuncture studies in hydropenic animals haveALLISON ET AL.
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FIG. 5. Absolute rate ofproximal reabsorption in rats with AICN and anti-GBM nephritis before and
after albumin.
shown that following expansion of plasma volume with hyperoncotic albumin, there
is a fall in proximal fractional reabsorption and a small, but significant, natriuresis
(16, 22-25). Our observations in normal Wistar rats are in keeping with these find-
ings, a significant rise in fractional sodium excretion being associated with a fall in
proximal fractional reabsorption. Whole kidney and single nephron glomerular
filtration rates rose slightly and insignificantly (kidney GFR by 6-15%, SNGFR by
3-9%), providing little evidence of intrarenal redistribution after hyperoncotic
albumin. Others have reported significant large and parallel increases in both kidney
GFR and SNGFR in the rat (22, 24, 26) after infusion of larger quantities of
albumin.
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The cause of the diminished fractional reabsorption observed after hyperoncotic
albumin in normal rats remains speculative. A significant role cannot be ascribed to
either aldosterone or ADH since in this as in other studies these substances were
infused throughout the study. There is also little support for the suggestion that
foreign albumin may have a direct "pharmacological" effect on the renal tubular
cells (27). Volume expansion of rats using hyperoncotic rat albumin has been found
to have similar effects.
In recent years there has been much discussion concerning the role ofperitubular
physical factors (hydrostatic and oncotic pressure) in the regulation of proximal
reabsorption, which has been based on the observations of Earley, Windhager, and
Brenner and their colleagues. In our studies, fractional and absolute reabsorption
fell after hyperoncotic albumin infusion, although in the latter instance this did not
reach statistical significance. Systemic blood pressure rose significantly. A small but
significant increase in efferent arteriolar hydrostatic pressure was measured during
the period immediately following the albumin infusion, which corresponded with the
phase of maximum diuretic and natriuretic activity. Proximal intratubular hydro-
static pressure was unchanged; calculated efferent oncotic pressure fell simul-
taneously by approximately 6 mm Hg. Although these observations might at first
sight appear to support a primary role for "physical factors," the validity of using
whole kidney filtration fraction to calculate efferent oncotic pressure and the nature
of the changes in interstitial oncotic and hydrostatic pressures after albumin are un-
known. Whole kidney filtration fraction and systemic protein concentration can be
used to calculate efferent oncotic pressure during hydropenia and after isovolaemic
exchange transfusion (28, 29). A poor correlation, however, has been found
following volume expansion or dehydration or both, and, hence, our calculated
efferent oncotic pressure after albumin may be misleading. In a recent study by
Knox et al. (23), direct measurements of peritubular capillary hydrostatic and
oncotic pressures were made and revealed no significant changes following hy-
peroncotic albumin infusion. Fractional and absolute proximal reabsorption,
however, were significantly reduced. Protein concentration in renal lymph was
significantly increased, and Knox has suggested that this indicates a rise in inter-
stitial oncotic pressure after albumin and, hence, a decrease in the Starling forces
acting across the peritubular capillary wall for reabsorption. At the same time,
however, they point out that a rise in oncotic interstitial fluid pressure might also be
expected to increase reabsorption since this force could facilitate fluid movement
across the basement membrane of the proximal tubules. Resolution of this problem
awaits the development of techniques capable of measuring interstitial fluid hydro-
static and oncotic pressures.
An alternative explanation of the diminished proximal reabsorption has been the
presumed release of a natriuretic factor liberated in response to an alteration in the
systemic circulation, i.e., arterial pressure, central venous pressure, plasma volume,
etc., following hyperoncotic albumin (30). More definite evidence exists for a second
hormonal influence, namely parathyroid hormone. Knox et al., in 1973 (17), found
that the natriuretic and phosphaturic effects of hyperoncotic albumin infusion in
rats were associated with an increase in parathyroid hormone excretion provoked by
a fall in ionized calcium levels following albumin infusion. Addition of sufficient cal-
cium to the infusate to prevent reduction in plasma ionized calcium levels resulted in
a failure of the albumin infusion to decrease significantly sodium reabsorption by the
proximal tubule. It is doubtful if the small quantity of calcium present in our in-
fusate (0.024 g/100 ml) would be sufficient to prevent binding of plasma calcium by
the infused albumin. The major natriuretic and diuretic effects were seen in the 45
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min immediately following the end of the albumin infusion. Knox et al. have found
this to coincide with the period of maximum phosphaturia, although systemic
parathyroid hormone levels were falling by this time.
Distal tubular sodium reabsorption was not examined in the present study.
Recently Stein et al. (24) and Knox and Gasser (25)demonstrated that in addition to
diminished proximal tubular reabsorption after albumin, alterations occur in so-
dium reabsorption in some distal segments ofthe nephron that have been attributed
to a medullary washout effect created by an increased plasma flow. Our finding of
decreased extraction of PAH and increase in renal plasma flow after albumin would
be in keeping with this hypothesis. Similar changeshave been previously described in
humans (31) anddogs (19) and have led to similar conclusions.
In addition, Knox and Gasser (25) found evidence of increased sodium
reabsorption (with increased potassium excretion) from the distal nephron after hy-
peroncotic albumin. In keeping with this, in our study, absolute and fractional po-
tassium excretion rose significantly following albumin.
The effect of hyperoncotic albumin infusion in the experimental animal with
glomerulonephritis has not previously been reported. In 1950 Orloff, Welt, and
Stowe (2) observed a diuretic and natriuretic response to hyperoncotic albumin in-
fusion in patients with nephrotic syndrome. This they attributed to inhibition of
ADH secretion and a rise in serum sodium concentration consequent to the ensuing
water diuresis. In salt-loaded, volume-expanded nephrotic patients, however,
Grausz, Lieberman, and Earley (32) found that theinfusion ofhyperoncotic albumin
resulted in increased fractional sodium reabsorption.
In our study, a significant diuresis occurred in both forms of glomerulonephritis
after hyperoncotic albumin; the pattern and magnitude of the response, however,
varied in the two conditions and was less marked than in the control rats. Thus, in
the more chronic AICN animals, there was a large rise in whole kidney and single
nephron filtration rate and a fall in proximal absolute reabsorption. We found no
alteration in either efferent oncotic or hydrostatic pressure after albumin in these
animals. The presence of marked single nephron heterogeneity, however, makes it
impossible to arrive at an accurate assessment of efferent oncotic pressure from
whole kidney filtration fraction without direct measurement. Although variations in
blood flow in individual glomeruli in chronic AICN rats almost certainly occur,
nephrons with higher filtration rates may have had higher filtration fractions and,
hence, higher efferent oncotic pressure. These nephrons also showed the largest fall
in absolute reabsorptive rate after hyperoncotic albumin. The smallest diuretic and
natriuretic responses occurred in the anti-GBM nephritic animals. In these rats no
changes occurred in single nephron filtration rate or proximal absolute reabsorptive
rate; hence, the small diuretic response observed must have been related to more
distal effects.
It is interesting to speculate why a smaller diuretic and natriuretic effect was seen
in the glomerulonephritic as compared to the control rat after similar quantities of
albumin. It should be noted that with the exception of some of the anti-GBM neph-
ritic rats, our animals were not, strictly speaking, "nephrotic" (i.e., proteinuria,
hypoproteinemia, and edema). There was no evidence that they were avidly retaining
sodium since their mean sodium excretion rate before albumin was not significantly
reduced below that of the control animals. In both forms of glomerulonephritis
there was evidence of diminished proximal fractional reabsorption before the
administration ofhyperoncotic albumin, and this was associated with a lower calcu-
lated efferent oncotic pressure. Distal tubular function was not measured, but
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overall fractional sodium excretion was increased. Maintenance of sodium balance
by increased fractional excretion of sodium is a well-recognized physiological adap-
tive response of the kidney to a variety of disease states (33). Although proximal
fractional reabsorption fell still further following albumin infusion, its overall effects
may have been somewhat attenuated by the prior diminished reabsorption related to
glomerulonephritis.
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